XImmune raises $0.67 million in financing round - MarketLine Financial Deals

XImmune raises $0.67 million in financing round

XImmune raises $0.67 million in financing round - MarketLine Financial Deals
XImmune raises $0.67 million in financing round
Published Feb 07, 2011
2 pages — Published Feb 07, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

XImmune AB, a Sweden-based company engaged in the development of pharmaceuticals to treat micro-induced inflammatory conditions, has raised SEK4.4 million ($0.67 million) in a financing round led by Lund University Bioscience AB.

  
Source:
Document ID
MA57302_110407
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "XImmune raises $0.67 million in financing round" Feb 07, 2011. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/XImmune-raises-0-67-million-in-financing-round-2052-58824>
  
APA:
MarketLine Financial Deals. (2011). XImmune raises $0.67 million in financing round Feb 07, 2011. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/XImmune-raises-0-67-million-in-financing-round-2052-58824>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.